This inventor holds 4 USPTO granted patents. Top assignees: Nippon Kayaku Kabushiki Kaisha, Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1980-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tikorozawa, JP (1980)
- Tokorozawa, JP (1980 - 1982)
- Saitama, JP (1985)
Company Filing History:

Years Active: 1980-1985
Title: Mamoru Kunishima: Innovator in Antibiotic Development
Introduction
Mamoru Kunishima is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of antibiotic research, holding a total of 4 patents. His work focuses on developing novel compounds that can be utilized in medical treatments.
Latest Patents
Among his latest patents is a derivative of cephamycin C. This invention discloses an N-benzenesulfonyl derivative of cephamycin C, which can be easily separated as a solid from an aqueous solution. This derivative serves as a valuable intermediate leading to cephamycin-type antibiotic substances. Another significant patent involves cleomycins, which are novel antibiotics represented by a specific formula. These compounds are particularly useful as chemotherapeutic agents for treating cancer and bacterial infections.
Career Highlights
Throughout his career, Mamoru Kunishima has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Nippon Kayaku Co., Ltd. and the Biseibutsu Kagaku Kenkyu Kai Foundation. His work in these organizations has contributed to advancements in antibiotic research and development.
Collaborations
Mamoru has collaborated with esteemed colleagues, including Hamao Umezawa and Akira Matsuda. These partnerships have fostered innovation and have been instrumental in the progress of his research endeavors.
Conclusion
Mamoru Kunishima's contributions to antibiotic development highlight his role as a significant inventor in the pharmaceutical field. His innovative patents and collaborations continue to impact medical science positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile